Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TRMT1 antibody (AA 609-659)

This anti-TRMT1 antibody is a Rabbit Polyclonal antibody detecting TRMT1 in WB and IP. Suitable for Human.
Catalog No. ABIN7451034

Quick Overview for TRMT1 antibody (AA 609-659) (ABIN7451034)

Target

See all TRMT1 Antibodies
TRMT1 (tRNA Methyltransferase 1 (TRMT1))

Reactivity

  • 31
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Human

Host

  • 30
Rabbit

Clonality

  • 31
Polyclonal

Conjugate

  • 19
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TRMT1 antibody is un-conjugated

Application

  • 21
  • 12
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)
  • Binding Specificity

    • 9
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 609-659

    Purpose

    Rabbit anti-TRMT1 Antibody, Affinity Purified

    Purification

    Affinity Purified

    Immunogen

    Between AA 609 and 659

    Isotype

    IgG
  • Application Notes

    IP: 2 - 10 μg/mg lysate

    WB: 1:500 - 1:2,500

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    TRMT1 (tRNA Methyltransferase 1 (TRMT1))

    Alternative Name

    TRMT1

    Background

    Background: tRNA 2,2-dimethylguanosine-26 methyltransferas (TRMT1) dimethylates a single guanine residue at position 26 of most tRNAs using S-adenosyl-L-methionine as donor of the methyl groups [taken from the Universal Protein Resource (UniProt) Q9NXH9].

    Gene ID

    55621

    NCBI Accession

    NP_060192

    UniProt

    Q9NXH9

    Pathways

    SARS-CoV-2 Protein Interactome
You are here:
Chat with us!